Aurobindo Pharma net profit down 28 percent to Rs 576 crore in Q4
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore as against Rs 794.3 crore in the corresponding previous period, it added.;
New Delhi: Aurobindo Pharma Ltd on Monday reported a 28 per cent decline in its consolidated net profit at Rs 576.14 crore in the fourth quarter ended March 2022.
The company had posted a consolidated net profit of Rs 801.18 crore in the same period of the preceding fiscal, Aurobindo Pharma said in a regulatory filing.
Consolidated total revenue from operations during the quarter under review stood at Rs 5,809.37 crore as compared to Rs 6,001.5 crore in the same period a year ago.
Total expenses in the fourth quarter were marginally higher at Rs 5,097.75 crore as against Rs 5,011.05 crore in the year-ago period.
During the quarter, US formulations revenue declined by 4.7 per cent on a year-on-year basis to Rs 2,728.1 crore, while the Europe formulations revenue stood at Rs 1,540.7 crore, largely flat on year-on-year basis, the company said.
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore as against Rs 794.3 crore in the corresponding previous period, it added.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.